Glaucoma

Glaucoma is a group of eye diseases characterized by progressive optic nerve damage and vision loss, often associated with elevated intraocular pressure. Because early disease may produce few noticeable symptoms, effective care depends on screening, risk assessment, timely diagnosis, sustained treatment, and regular monitoring. Clinical priorities increasingly center on preserving functional vision over a patient’s lifetime rather than responding only after substantial damage has occurred.

The glaucoma landscape is being transformed by broader use of advanced imaging, automated visual-field testing, pressure monitoring, and risk-based follow-up. Treatment pathways are also becoming more individualized, combining medicines, laser procedures, and surgery according to disease severity, adherence, anatomy, and progression risk. At the system level, teleophthalmology, remote review, electronic records, and coordinated referral pathways can help address delayed diagnosis and improve continuity between primary eye care and specialist services.

Artificial intelligence can support glaucoma care by identifying suspicious optic-nerve or retinal features, prioritizing referrals, analyzing imaging and visual-field trends, and helping clinicians recognize progression. Its practical value depends on representative training data, transparent validation, interoperability with clinical workflows, and human oversight. AI should complement-not replace-comprehensive examination, clinical judgment, and patient communication, particularly where image quality, coexisting disease, or atypical presentations may reduce algorithmic reliability.

North America generally emphasizes risk-based screening, specialist capacity, adherence support, and digital monitoring. Latin America faces uneven access, affordability constraints, and referral delays, making decentralized detection and workforce development important. Europe’s priorities include coordinated chronic-care pathways, aging-population needs, and equitable access across health systems. The Middle East is strengthening specialist services while addressing variation in access and workforce distribution. Africa requires greater investment in primary eye care, diagnosis, medicines, and surgical capacity. Asia-Pacific combines rapidly expanding demand with highly variable infrastructure, creating opportunities for scalable screening, teleophthalmology, and locally appropriate care models.

ASEAN countries can benefit from shared training, referral standards, and adaptable screening models across diverse health systems. BRICS members face substantial variation in population needs, affordability, rural access, and specialist distribution, favoring collaboration on scalable diagnostics and service delivery. The European Union can use cross-border research, harmonized quality practices, and coordinated chronic-care approaches while respecting national reimbursement structures. G7 systems are positioned to advance evidence generation, digital integration, and aging-related care models. GCC countries can build on concentrated specialist infrastructure while improving prevention, continuity, and workforce sustainability. NATO members, spanning varied health systems, can strengthen common clinical education, preparedness, and interoperability practices.

Australia can prioritize rural and remote access, Indigenous eye health, and coordinated monitoring. Brazil and Mexico need stronger primary-care detection, referral continuity, and affordability across geographically diverse populations. Canada should continue addressing rural specialist access and continuity for aging patients. China and India require scalable screening, workforce expansion, and technology-enabled triage suited to large and diverse populations. Japan and South Korea can focus on aging-related disease management, adherence, and longitudinal monitoring. France, Germany, Italy, and Spain can strengthen coordinated care, early detection, and system integration. The United Kingdom can build on structured eye-care pathways while addressing capacity and follow-up pressures. The United States can emphasize equitable screening, adherence, and integration of advanced diagnostics into routine care. Russia faces the need to sustain specialist access, diagnostic quality, and continuity across extensive geography.

Leaders should design care models around earlier identification and measurable preservation of vision, with referral protocols that connect primary care, optometry, ophthalmology, and community services. Investments should favor validated imaging and monitoring tools, interoperable data systems, and AI that has been tested across relevant populations and clinical settings. Patient-centered adherence programs, affordable treatment pathways, and culturally appropriate education are essential because glaucoma management is typically long term. Organizations should also track diagnostic delays, loss to follow-up, progression, treatment persistence, and access disparities to guide continuous improvement.

This executive summary uses a structured qualitative assessment of glaucoma care, focusing on disease detection, diagnosis, monitoring, treatment delivery, digital transformation, and access. Regional, group, and country perspectives are integrated by comparing demographic pressures, health-system organization, specialist availability, infrastructure, affordability, and policy priorities. Artificial intelligence is assessed according to potential clinical applications and implementation requirements, including validation, bias management, workflow integration, privacy, and human oversight. No market estimates, market sizing, market shares, or forecasts are used.

Glaucoma outcomes improve when disease is identified before irreversible vision loss, treatment is matched to individual risk, and monitoring continues reliably over time. The most durable progress will come from combining clinical expertise with accessible diagnostics, coordinated referral systems, responsible digital tools, and patient support. Regional and country-specific implementation matters: approaches must reflect local workforce, infrastructure, affordability, and population needs while maintaining consistent standards for safety and quality.